Recombinant activated factor VII treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, and efficacy and safety outcomes | Zendy

AI Assistant Blog Pricing

Recombinant activated factor VII treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, and efficacy and safety outcomes

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.